Smart Money Is Betting Big In REGN Options
Portfolio Pulse from Benzinga Insights
Financial giants are making bearish moves on Regeneron Pharmaceuticals (NASDAQ:REGN) through options trading. Analysis shows 50% bearish sentiment with significant trades in puts and calls. The stock is currently down 3.02% at $1110.5, with analysts providing mixed ratings and price targets.
September 23, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is experiencing bearish sentiment in options trading, with 50% of trades showing bearish tendencies. The stock is down 3.02% at $1110.5, and analysts have mixed ratings with price targets ranging from $1015 to $1282.
The article highlights significant bearish sentiment in options trading for REGN, with 50% of trades being bearish. The stock price has decreased by 3.02%, indicating a negative short-term impact. Analysts have provided mixed ratings, adding to the uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100